- How firms redesigned delivery to increase margin, reduce risk and improve client outcomes.
- Real examples of firms /How they reduced rework, chasing, manual entry, onboarding delays
- How they used automation to remove friction, not replace people
- The measurable impact on margin, WIP, write downs, and client satisfaction/ What “good” looks like
Archives: Agenda
CLIENT EXPERIENCE & HYPER PERSONALISATION
Chairperson: Adil Bundeally, Transformation Director, Risk Advisor & Interim Executive, Lloyds (Former)
THE FUTURE OF OPERATIONS
Chairperson: Ian Woodhouse, Strategy Advisor, Multrees Investor Services
END OF CONFERENCE
Understanding the true value of patient-led navigation within the clinical research team
- The Community Navigator (CN)- Patient Led Navigation demonstrating the feasibility
- Quantifiable Patient Improvement – increased Clinical Trials Knowledge and Beliefs Scale (CHEKS) scores
- Reframing Patient-Led Navigation – as a structured solution (option) vs traditional navigation model, to improve equity, patient experience, and engagement in oncology research
CLOSING KEYNOTE: Engineering tumor selectivity: The Rise of a Masked CD47 Biologic and a China-enabled development strategy
- Evolution of masking technology to achieve protease-mediated, tumor-specific drug activation
- Applications of masking technology in oncology and immunology, including the ubiquitous macrophage checkpoint, CD47, and cytokines
- Development of a China-anchored early development path, including considerations of IITs, China IND, and US IND.